trending Market Intelligence /marketintelligence/en/news-insights/trending/awggxlnpv6t5xu9n91ox2q2 content esgSubNav
Log in to other products


Looking for more?

Contact Us
In This List

Entera Bio appoints chairman


COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021


Climate Credit Analytics: Linking climate scenarios to financial impacts


Global M&A Infographic Q1 2021


Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge

Entera Bio appoints chairman

Entera Bio Ltd. named Gerald Lieberman as board chairman.

Lieberman was formerly the president and COO of AllianceBernstein LP, a privately owned investment manager, until 2009. Before that, he was with Sanford C. Bernstein & Co. Inc. as the senior vice president for finance and administration.

Israel-based Entera Bio develops and commercializes orally delivered treatments for orphan indications and other areas with significant unmet medical needs. The company is developing an oral formulation of the parathyroid hormone to treat hypoparathyroidism and osteoporosis.